SEMAGLUTIDE INJECTIONS

What is Semaglutide?
In simple terms, Semaglutide improves insulin resistance. This allows calories and fat to be burned, while improving energy. Semaglutide is peptide that works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), which targets an area of the brain that regulates appetite and food intake. By controlling blood sugar spikes and lowering blood sugar, as well as reducing appetite and cravings, energy levels are more consistent. Semaglutide is administered by a subcutaneous injection, commonly dosed once weekly. Dosing may be increased after one month. Originally used for diabetes and sold under the name Ozempic, it was FDA approved for weight loss in June 2021.

How Does Semaglutide Work?

1. Delays how quickly stomach digests food, leading to feelings of fullness and satisfaction with smaller meal sizes.

2. Slows intestinal mortality so you will feel fuller longer after meals.

3. Lowers blood sugars in part by reducing the production of sugar in the liver.

4. Stimulates insulin secretion by the pancreas.

 

Benefits of Semaglutide

• Real Weight Loss results of up to 2-4 pounds per week

• Powerful appetite suppressant

• Improves insulin resistance, burns fat and boosts energy

 

Side Effects/Contraindications

1. The most commonly reported side effect is weight loss. However, some have reported nausea, vomiting, diarrhea, stomach pain, or constipation. However, these side effects are typically mild and tend to improve over time as the body adjusts to the medication.

2. The rarest risks of serious effects, increase in patients with hypoglycemia, kidney problems, and risk of allergic reactions. This medication is ideal for those who are in good health with no kidney or liver issues and who wish to lose weight.

3. The medication is not insulin and should not be used if you have type 1 diabetes or develop diabetic ketoacidosis.

 

Risk of Thyroid C–Cell Tumors
If you or any family members have been diagnosed with multiple endocrine neoplasia syndrome Type 2 or medullary thyroid cancer, you should not take Semaglutide. If you have ever had pancreatitis, consult your primary care doctor prior to starting Semaglutide because it can increase the risk of developing pancreatitis.

Warning/Contraindication for Females
There are limited data from the use of Semaglutide in pregnant people. Therefore, Semaglutide should not be used during pregnancy. If a patient wishes to become pregnant, or pregnancy occurs, Semaglutide should be discontinued.